COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders [NG167], NICE (updated 30th April 2020)

Latest updates On 30 April 2020 It was highlighted that immunosuppression may continue for some time after some drugs are stopped.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news